Friday, August 15, 2014 4:13:27 PM
Cost of sales is pretty much identical, near $85K.
General expenses are down, around $50K.
Net profit is halved relative to last Q, $2,819 relative to $6,345.
They end the Q with $2,241 of cash, last than last Q's $6,655.
------------
10,000,0000 series D shares have been issued. Long Term Liabilities have decreased by $7,162,511 yo $0.
The O/S is given as 6,700,000,000 shares, roughly a 1 billion shares decrease in O/S.
The 1 billions shares have been "Repurchased"!
C. Beneficial Shareholders
There are no holders possessing 10% or more of the Issuer’s outstanding common stock.
2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this disclosure statement; and
/s/ Peter Michaels
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM